RXRX Cash & Equivalents
Recursion Pharmaceuticals Inc Clas · Cash & Equivalents
RXRX Cash & Equivalents
Latest reported$743.29Mperiod ending
RXRX FY Cash & Equivalents ($69.88M → $743.29M)
Annual Cash & Equivalents
High-resolution chart · PNG
RXRX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 743,294,000 | |
| 594,350,000 | |
| 391,565,000 | |
| 549,912,000 | |
| 285,116,000 | |
| 262,126,000 | |
| 69,883,000 |